B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Olodanrigan

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Olodanrigan, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

telmisartan
2 shared targets
Irbesartan
2 shared targets · score 53.1
Losartan
2 shared targets · score 74.7
candesartan
2 shared targets · score 56.7
Loading evidence profile...

This evidence profile for Olodanrigan is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.